GIS
28
2
MU
36
5
MAS
56
5
OKE
81
3
DVN
18
2
LMT
32
-12
PPL
59
5
DHI
44
-4
RHI
57
3
EXPD
45
8
USB
61
11
STT
64
4
RRC
59
-4
FDX
40
4
ADSK
68
2
WEC
55
2
EMN
56
7
AMP
73
4
AMG
52
2
KO
44
2
GIS
28
2
MU
36
5
MAS
56
5
OKE
81
3
DVN
18
2
LMT
32
-12
PPL
59
5
DHI
44
-4
RHI
57
3
EXPD
45
8
USB
61
11
STT
64
4
RRC
59
-4
FDX
40
4
ADSK
68
2
WEC
55
2
EMN
56
7
AMP
73
4
AMG
52
2
KO
44
2
Financhill
Back

Anebulo Pharmaceuticals Quote, Financials, Valuation and Earnings

Invest. Do Good. Get Rewarded. Just $0.25/Share!

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
38

ANEB
Anebulo Pharmaceuticals

Last Price:
1.46
Seasonality Move:
11.06%

7 Day Trial

ALL ACCESS PASS

$ 7

Start Investing Smarter Unlock Louis Navellier's Stock Grader for free

Louis' clients have paid up to $30,000 for these insights - now you can try it at no cost.

Anebulo Pharmaceuticals Price Quote

$1.46
-0.04 (-3.95%)
(Updated: November 22, 2024 at 5:11 AM ET)

Anebulo Pharmaceuticals Key Stats

Sell
38
Anebulo Pharmaceuticals (ANEB) is a Sell
Day range:
$1.25 - $1.68
52-week range:
$1.25 - $3.30
Dividend yield:
0%
P/E ratio:
0.00
P/S ratio:
0.00
P/B ratio:
20.49%
Volume:
13.9K
Avg. volume:
5.1K
1-year change:
-30.23%
Market cap:
$38.9M
Revenue:
$0
EPS:
$-0.3

How Much Does Anebulo Pharmaceuticals Make?

Data Unavailable

Is Anebulo Pharmaceuticals Growing As A Company?

Data Unavailable

Anebulo Pharmaceuticals Stock Price Performance

What Is Anebulo Pharmaceuticals 52-Week High & Low?

Anebulo Pharmaceuticals Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy Anebulo Pharmaceuticals?

Is Anebulo Pharmaceuticals Cash Flow Positive?

  • What Is ANEB Cash Flow From Operations?
    Cash flow from operations (TTM) is -$7.1M
  • What Is Anebulo Pharmaceuticals’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $0
  • What Is Anebulo Pharmaceuticals’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $0

Anebulo Pharmaceuticals Return On Invested Capital

Data Unavailable

Anebulo Pharmaceuticals Earnings Date & Stock Price

Anebulo Pharmaceuticals Competitors

Anebulo Pharmaceuticals Dividend Yield

Anebulo Pharmaceuticals Analyst Estimates

YoY Growth Past Surprise
EPS: 0% -60%
Revenue: 0% 0%

Analyst Recommendations

Buy Recommendations: 1
Hold Recommendations: 0
Sell Recommendations: 0
Price Target: 8.00
Upside from Last Price: 433.33%

Major Shareholders

  • How many ANEB shares are owned by institutional investors?
    8.4M ANEB shares are owned by institutional investors
  • How many ANEB shares are owned by insiders?
    3M ANEB shares are owned by insiders